- Home
- SHFS vs PMN Comparison
SHFS vs PMN Comparison
Compare SHFS & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHFS
- PMN
- Stock Information
- Founded
- SHFS 2015
- PMN 2004
- Country
- SHFS United States
- PMN Canada
- Employees
- SHFS N/A
- PMN N/A
- Industry
- SHFS Finance: Consumer Services
- PMN Pharmaceuticals and Biotechnology
- Sector
- SHFS Finance
- PMN Health Care
- Exchange
- SHFS Nasdaq
- PMN Nasdaq
- Market Cap
- SHFS 20.8M
- PMN 17.5M
- IPO Year
- SHFS N/A
- PMN N/A
- Fundamental
- Price
- SHFS $2.78
- PMN $0.52
- Analyst Decision
- SHFS
- PMN Strong Buy
- Analyst Count
- SHFS 0
- PMN 2
- Target Price
- SHFS N/A
- PMN $4.50
- AVG Volume (30 Days)
- SHFS 26.5K
- PMN 59.5K
- Earning Date
- SHFS 05-21-2025
- PMN 05-12-2025
- Dividend Yield
- SHFS N/A
- PMN N/A
- EPS Growth
- SHFS N/A
- PMN N/A
- EPS
- SHFS N/A
- PMN N/A
- Revenue
- SHFS $13,956,453.00
- PMN N/A
- Revenue This Year
- SHFS N/A
- PMN N/A
- Revenue Next Year
- SHFS N/A
- PMN N/A
- P/E Ratio
- SHFS N/A
- PMN N/A
- Revenue Growth
- SHFS N/A
- PMN N/A
- 52 Week Low
- SHFS $1.84
- PMN $0.47
- 52 Week High
- SHFS $15.20
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- SHFS 50.65
- PMN 46.07
- Support Level
- SHFS $2.25
- PMN $0.47
- Resistance Level
- SHFS $2.83
- PMN $0.61
- Average True Range (ATR)
- SHFS 0.27
- PMN 0.06
- MACD
- SHFS 0.12
- PMN 0.00
- Stochastic Oscillator
- SHFS 94.62
- PMN 35.71
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.